Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials

BACKGROUND: The optimal dose of tenecteplase vs. alteplase for acute ischemic stroke (AIS) has yet to be established. Therefore, we included the latest randomized controlled trials (RCT) to assess the efficacy and safety of different doses of tenecteplase vs. alteplase for AIS within 4.5 hours of sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Huo, Wang, Xue, Quan, Xuemei, Chen, Shijian, Qin, Bin, Liang, Shuolin, Huang, Qiuhui, Zhang, Jian, Liang, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274135/
https://www.ncbi.nlm.nih.gov/pubmed/37333014
http://dx.doi.org/10.3389/fneur.2023.1176540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274135/
https://www.ncbi.nlm.nih.gov/pubmed/37333014
http://dx.doi.org/10.3389/fneur.2023.1176540

Ejemplares similares